The Milltrust India Fund adopts an actively managed long-biased multi-cap strategy with a value approach in India. The strategy involves the identification of stocks with a long-term investment perspective that blends large cap heavyweights with off-benchmark mid cap stocks. Investments also follow a thematic based selection discipline with a focus on niche sectors and a contrarian approach. Hedging overlay is based on quantitative and qualitative metrics to mitigate short-term market volatility through the use of index future shorts and cash management.
UTI Asset Management Company (USD25bn AUM) is the oldest and one of the largest Asset Management Company in India. T Rowe Price acquired a 26% stake in the company in 2010. UTI International (Singapore) Pte Ltd, a fully-owned subsidiary of UTI AMC, is the flagship company representing the offshore interests of UTI AMC. It has two incorporated entities (in Guernsey and Singapore), and branch / representative offices in Dubai, Mauritius and United Kingdom.
The Fund is managed by an experienced team of India specialists, led by N. Murali and V. Srivatsa who have been running the highly-rated strategy for over 5 years. The managers are supported by a dedicated team of over 20 investment professionals, one of the largest India dedicated teams amongst its peers.